These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38356472)

  • 1. Association of region-specific hippocampal reduction of neurogranin with inflammasome proteins in
    Vontell RT; Gober R; Dallmeier J; Brzostowicki D; Barreda A; Blennow K; Zetterberg H; Kvartsberg H; Gultekin SH; de Rivero Vaccari JP; Bramlett HM; Dietrich WD; Keane RW; Davis DA; Rundek T; Sun X
    Alzheimers Dement (N Y); 2024; 10(1):e12444. PubMed ID: 38356472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
    Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
    Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to Alzheimer's disease alters inflammasome activity after traumatic brain injury.
    Johnson NH; Kerr NA; de Rivero Vaccari JP; Bramlett HM; Keane RW; Dietrich WD
    Transl Res; 2023 Jul; 257():66-77. PubMed ID: 36758791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
    Kvartsberg H; Lashley T; Murray CE; Brinkmalm G; Cullen NC; Höglund K; Zetterberg H; Blennow K; Portelius E
    Acta Neuropathol; 2019 Jan; 137(1):89-102. PubMed ID: 30244311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
    Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurogranin in Alzheimer's disease and ageing: A human post-mortem study.
    Saunders T; Gunn C; Blennow K; Kvartsberg H; Zetterberg H; Shenkin SD; Cox SR; Deary IJ; Smith C; King D; Spires-Jones T
    Neurobiol Dis; 2023 Feb; 177():105991. PubMed ID: 36623608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
    Sanfilippo C; Forlenza O; Zetterberg H; Blennow K
    J Neural Transm (Vienna); 2016 Dec; 123(12):1443-1447. PubMed ID: 27531278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.
    Willemse EAJ; Sieben A; Somers C; Vermeiren Y; De Roeck N; Timmers M; Van Broeckhoven C; De Vil B; Cras P; De Deyn PP; Martin JJ; Teunissen CE; Engelborghs S; Bjerke M
    Neurobiol Aging; 2021 Dec; 108():99-109. PubMed ID: 34551375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer's and Parkinson's Disease.
    Hulse J; Bhaskar K
    Front Mol Neurosci; 2022; 15():805169. PubMed ID: 35185469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease.
    Hanslik KL; Ulland TK
    Front Neurol; 2020; 11():570711. PubMed ID: 33071950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex.
    Sun X; Wang Q; Blennow K; Zetterberg H; McCarthy M; Loewenstein DA; Vontell R; Yue Z; Zhang B
    Alzheimers Dement (N Y); 2021; 7(1):e12162. PubMed ID: 33860070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kivisäkk P; Carlyle BC; Sweeney T; Quinn JP; Ramirez CE; Trombetta BA; Mendes M; Brock M; Rubel C; Czerkowicz J; Graham D; Arnold SE
    Alzheimers Res Ther; 2022 Apr; 14(1):58. PubMed ID: 35461266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.
    Yang Z; Liu J; Wei S; Deng J; Feng X; Liu S; Liu M
    Front Pharmacol; 2022; 13():1077222. PubMed ID: 36699095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER stress associated TXNIP-NLRP3 inflammasome activation in hippocampus of human Alzheimer's disease.
    Ismael S; Wajidunnisa ; Sakata K; McDonald MP; Liao FF; Ishrat T
    Neurochem Int; 2021 Sep; 148():105104. PubMed ID: 34153352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.
    Portelius E; Olsson B; Höglund K; Cullen NC; Kvartsberg H; Andreasson U; Zetterberg H; Sandelius Å; Shaw LM; Lee VMY; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk DA; McCluskey L; Elman L; McBride J; Toledo JB; Trojanowski JQ; Blennow K
    Acta Neuropathol; 2018 Sep; 136(3):363-376. PubMed ID: 29700597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice.
    Yuan H; Chen S; Duncan MR; de Rivero Vaccari JP; Keane RW; Dalton Dietrich W; Chou TH; Benny M; Schmidt AF; Young K; Park KK; Porciatti V; Elizabeth Hartnett M; Wu S
    Angiogenesis; 2024 Aug; 27(3):423-440. PubMed ID: 38709389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer's Disease.
    Scott XO; Stephens ME; Desir MC; Dietrich WD; Keane RW; de Rivero Vaccari JP
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis.
    Wang Z; Yang J; Zhu W; Tang Y; Jia J
    Int J Neurosci; 2022 Dec; 132(12):1245-1253. PubMed ID: 33527855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.